Brief: DURECT Corp Announces U.S. FDA Approval Of POSIMIR For Post-Surgical Pain Reduction For Up To 72 Hours Following Arthroscopic Subacromial Decompression

DURECT

02/02/2021 13:24

Feb 2 (Reuters) - DURECT Corp  DRRX.O :
    * DURECT CORPORATION ANNOUNCES U.S. FDA APPROVAL OF POSIMIR®
FOR
POST-SURGICAL PAIN REDUCTION FOR UP TO 72 HOURS FOLLOWING
ARTHROSCOPIC SUBACROMIAL DECOMPRESSION

Source text for Eikon:  ID:nPn5RVt28a 
Further company coverage:  DRRX.O 

 ((Reuters.Briefs@thomsonreuters.com;))